annual EBIT:
-$301.15M-$78.09M(-35.01%)Summary
- As of today (July 26, 2025), ABCL annual earnings before interest & taxes is -$301.15 million, with the most recent change of -$78.09 million (-35.01%) on December 31, 2024.
- During the last 3 years, ABCL annual EBIT has fallen by -$523.04 million (-235.71%).
- ABCL annual EBIT is now -232.63% below its all-time high of $227.06 million, reached on December 31, 2022.
Performance
ABCL EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$58.51M+$10.70M(+15.47%)Summary
- As of today (July 26, 2025), ABCL quarterly earnings before interest & taxes is -$58.51 million, with the most recent change of +$10.70 million (+15.47%) on March 31, 2025.
- Over the past year, ABCL quarterly EBIT has dropped by -$6.89 million (-13.34%).
- ABCL quarterly EBIT is now -125.42% below its all-time high of $230.14 million, reached on March 31, 2022.
Performance
ABCL quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$308.03M-$6.89M(-2.29%)Summary
- As of today (July 26, 2025), ABCL TTM earnings before interest & taxes is -$308.03 million, with the most recent change of -$6.89 million (-2.29%) on March 31, 2025.
- Over the past year, ABCL TTM EBIT has dropped by -$94.86 million (-44.50%).
- ABCL TTM EBIT is now -188.00% below its all-time high of $350.03 million, reached on September 30, 2022.
Performance
ABCL TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ABCL EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -35.0% | -13.3% | -44.5% |
| 3 y3 years | -235.7% | -125.4% | -205.9% |
| 5 y5 years | -10000.0% | -5257.8% | -7189.9% |
ABCL EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -232.6% | at low | -246.7% | +35.1% | -188.0% | at low |
| 5 y | 5-year | -232.6% | at low | -125.4% | +35.1% | -188.0% | at low |
| alltime | all time | -232.6% | at low | -125.4% | +35.1% | -188.0% | at low |
ABCL EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$58.51M(-15.5%) | -$308.03M(+2.3%) |
| Dec 2024 | -$301.15M(+35.0%) | -$69.21M(-23.2%) | -$301.15M(+2.2%) |
| Sep 2024 | - | -$90.17M(+0.0%) | -$294.61M(+14.9%) |
| Jun 2024 | - | -$90.14M(+74.6%) | -$256.50M(+20.3%) |
| Mar 2024 | - | -$51.62M(-17.6%) | -$213.17M(-4.4%) |
| Dec 2023 | -$223.05M(-198.2%) | -$62.68M(+20.4%) | -$223.05M(+13.5%) |
| Sep 2023 | - | -$52.06M(+11.2%) | -$196.48M(+88.0%) |
| Jun 2023 | - | -$46.81M(-23.9%) | -$104.53M(+61.9%) |
| Mar 2023 | - | -$61.50M(+70.3%) | -$64.58M(-128.4%) |
| Dec 2022 | $227.06M | -$36.10M(-190.5%) | $227.06M(-35.1%) |
| Sep 2022 | - | $39.88M(-681.3%) | $350.03M(+22.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$6.86M(-103.0%) | $286.43M(-1.5%) |
| Mar 2022 | - | $230.14M(+164.9%) | $290.91M(+31.0%) |
| Dec 2021 | $221.90M(+35.0%) | $86.86M(-466.3%) | $221.98M(-24.5%) |
| Sep 2021 | - | -$23.72M(+893.5%) | $293.99M(-7.3%) |
| Jun 2021 | - | -$2.39M(-101.5%) | $317.27M(-2.9%) |
| Mar 2021 | - | $161.22M(+1.5%) | $326.66M(+98.8%) |
| Dec 2020 | $164.34M(-8309.0%) | $158.87M(<-9900.0%) | $164.34M(+4099.2%) |
| Sep 2020 | - | -$431.00K(-106.2%) | $3.91M(-9.9%) |
| Jun 2020 | - | $7.00M(-740.7%) | $4.34M(-263.9%) |
| Mar 2020 | - | -$1.09M(-30.0%) | -$2.65M(+70.0%) |
| Dec 2019 | -$2.00M(-484.3%) | -$1.56M | -$1.56M |
| Dec 2018 | $521.00K | - | - |
FAQ
- What is AbCellera Biologics Inc. annual earnings before interest & taxes?
- What is the all time high annual EBIT for AbCellera Biologics Inc.?
- What is AbCellera Biologics Inc. annual EBIT year-on-year change?
- What is AbCellera Biologics Inc. quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for AbCellera Biologics Inc.?
- What is AbCellera Biologics Inc. quarterly EBIT year-on-year change?
- What is AbCellera Biologics Inc. TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for AbCellera Biologics Inc.?
- What is AbCellera Biologics Inc. TTM EBIT year-on-year change?
What is AbCellera Biologics Inc. annual earnings before interest & taxes?
The current annual EBIT of ABCL is -$301.15M
What is the all time high annual EBIT for AbCellera Biologics Inc.?
AbCellera Biologics Inc. all-time high annual earnings before interest & taxes is $227.06M
What is AbCellera Biologics Inc. annual EBIT year-on-year change?
Over the past year, ABCL annual earnings before interest & taxes has changed by -$78.09M (-35.01%)
What is AbCellera Biologics Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of ABCL is -$58.51M
What is the all time high quarterly EBIT for AbCellera Biologics Inc.?
AbCellera Biologics Inc. all-time high quarterly earnings before interest & taxes is $230.14M
What is AbCellera Biologics Inc. quarterly EBIT year-on-year change?
Over the past year, ABCL quarterly earnings before interest & taxes has changed by -$6.89M (-13.34%)
What is AbCellera Biologics Inc. TTM earnings before interest & taxes?
The current TTM EBIT of ABCL is -$308.03M
What is the all time high TTM EBIT for AbCellera Biologics Inc.?
AbCellera Biologics Inc. all-time high TTM earnings before interest & taxes is $350.03M
What is AbCellera Biologics Inc. TTM EBIT year-on-year change?
Over the past year, ABCL TTM earnings before interest & taxes has changed by -$94.86M (-44.50%)